跳至主要内容
临床试验/NCT04119882
NCT04119882已完成不适用

Early Detection of Myocardial Ischaemia in Suspected Acute Coronary Syndromes by Apo J-Glyc as a Novel Pathologically-based Ischaemia Biomarker

Glycardial Diagnostics S.L.10 个研究点 分布在 2 个国家目标入组 404 人开始时间: 2019年8月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
404
试验地点
10
主要终点
Cut-off value point of Apo J-Gly levels at admission for the early diagnosis of cardiac ischaemia

研究概览

简要总结

The objective of the study is to assess the performance characteristics of Apo J-Glyc as a novel biomarker for the early detection of myocardial ischaemia in patients with suspected acute coronary syndromes.

详细描述

This in vitro diagnosis clinical validation will test the Performance Characteristics of Apo J-Glyc measured with a novel in vitro diagnostic (IVD) test. Blood samples from eligible consenting subjects will be collected at hospital admission, throughout different post admission times (1h, 3h, 24h and 72h or discharge). The quantification of circulating Apo J-Glyc levels will be analysed in correlation with clinical data providing information about Apo J-Glyc as an ischaemia biomarker and its diagnostic and 6-months prognostic value.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age equal or above 18 years old
  • Chest pain of suspected cardiac origin
  • Signature of informed consent
  • Able and willing to comply with study requirements

排除标准

  • Prior inclusion in the same study
  • Life expectancy less than 6 months
  • Previous inclusion in a therapy-related clinical trial (except clinical trials testing Medical Devices such as stents and/or balloons)

结局指标

主要结局

Cut-off value point of Apo J-Gly levels at admission for the early diagnosis of cardiac ischaemia

时间窗: 3 hours

Cut-off value point of Apo J-Gly levels at admission for the early diagnosis of cardiac ischaemia as compared to final diagnosis at discharge following routine practice to manage chest pain patients with possible ACS.

Specificity

时间窗: 3 hours

Specificity results will be generated from subject's blood collected at different collection time points.

Area under the Receiver Operating characteristic Curve (A-ROC curve)

时间窗: 3 hours

Area under the Receiver Operating characteristic Curve will be used to determine the optimum clinical sensitivity and specificity. Results will be generated from subject's blood collected at different collection time points.

Sensitivity

时间窗: 3 hours

Sensitivity results will be generated from subject's blood collected at different collection time points.

Positive Predictive Value (PPV)

时间窗: 3 hours

Positive Predictive Value results will be generated from subject's blood collected at different collection time points.

Negative Predictive Value (NPV)

时间窗: 3 hour

Negative Predictive Value results will be generated from subject's blood collected at different collection time points.

次要结局

  • Prognosis and risk-stratification. Incidence of Major following Adverse Cardiac Event (MACE).(From admission to up to 6 months)

研究者

发起方
Glycardial Diagnostics S.L.
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验

Early Detection of Myocardial Ischaemia in Suspected... | 临床试验